BCM Ventures
Overview
BCM Ventures is the commercial engine of Baylor College of Medicine, created to support the translation of academic knowledge and intellectual assets for the benefit of society . The Ventures team is focused on building a thriving innovation ecosystem with a culture of commercialization centered around maximizing the impact of BCM knowledge and discoveries . BCMV engages with university innovators, entrepreneurs and industry experts to develop ideas and identify best commercial pathways .
Portfolio Companies
5
Website
bcm.eduInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Medley Therapeutics, Inc. | Jan 2022 | Series B | Co-investor |
| Phiogen | Jan 2023 | Seed | Lead |
| Velvet Therapeutics | Sep 2023 | VC Round | Co-investor |
| Nemea Therapeutics, Inc. | Nov 2025 | Pre Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BCM Ventures based?
BCM Ventures is headquartered in Houston, Texas, United States.
When was BCM Ventures founded?
Founding year information for BCM Ventures is not publicly available.
How many portfolio companies does BCM Ventures have?
BCM Ventures has 5 portfolio companies in Caplight's dataset.
What are some companies in BCM Ventures's portfolio?
Portfolio companies visible on Caplight include Medley Therapeutics, Inc., Phiogen, Velvet Therapeutics, Nemea Therapeutics, Inc..
What was BCM Ventures's most recent investment shown here?
BCM Ventures's most recent investment in this portfolio sample was in Nemea Therapeutics, Inc. in 2025.
What sectors does BCM Ventures focus on?
BCM Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does BCM Ventures focus on?
Stage focus information for BCM Ventures is not publicly available.
What is BCM Ventures's AUM?
BCM Ventures's assets under management are estimated between $0.0 and $50.0M.